about
Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancerNDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498.Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes.Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression.FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.Hyperthermia-induced NDRG2 upregulation inhibits the invasion of human hepatocellular carcinoma via suppressing ERK1/2 signaling pathway.Up-regulation of pVHL along with down-regulation of HIF-1α by NDRG2 expression attenuates proliferation and invasion in renal cancer cellsAdenovirus-mediated NDRG2 inhibits the proliferation of human renal cell carcinoma cell line OS-RC-2 in vitro.NDRG4 is downregulated in glioblastoma and inhibits cell proliferation.N-myc downstream regulated gene 2 overexpression reduces matrix metalloproteinase-2 and -9 activities and cell invasion of A549 lung cancer cell line in vitroNDRG4 is required for cell cycle progression and survival in glioblastoma cells.Clinical significance of NDRG3 in patients with breast cancer.Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers.Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.Variation of NDRG2 and c-Myc expression in rat heart during the acute stage of ischemia/reperfusion injury.N-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma.Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization.NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
P2860
Q26778509-B208DF16-FDF3-4152-975C-999EA6ADB421Q34067733-3CB4C0C2-DA5F-4E42-842E-87DCA1EB5D69Q34128093-EFFE7AF0-73EF-4E4F-9A93-619543A2D80FQ34393043-8EEC21E7-0120-4F00-9892-EBE387B677A3Q34440796-9EE76F6A-70E3-415B-92F0-CFD6DBA07CBEQ34695439-22C6891F-DF54-4DD6-AD2E-28027735D970Q35078332-6CD29B5E-F8BD-4E40-AB10-56C99D298AB4Q35170646-044CFCF8-5FB4-4FCD-AAC2-1B86269D8E9BQ35920078-4E8B5CD5-CE1A-46A6-BDB6-D4EA7A1E2BEDQ36249331-A365A502-386A-4EC9-B437-D554BA63D458Q37375751-F60D35B0-D55B-4983-B9A1-CBB59F538EE8Q38741790-67D3515B-E311-45DE-BFBD-A8DACA2D10E1Q38817380-FBD2DB06-1C0A-43C5-8828-EB39DADBEC45Q42062213-102F7C3D-272F-4DE9-8935-5F119C4B97BCQ44019414-174D3B2D-C164-4C29-958A-C99F1810D968Q46077517-4288A05C-25B7-4AB0-A80A-596508976D96Q50422609-7E92FAA3-20CE-43A9-9BC1-B4F88A3C8CC4Q50926414-3960088F-951F-471A-BB18-317436C7E9D7Q54110223-93D746FF-6BB7-46F4-BA52-FACB45E67DD8Q54329310-F662E777-C39D-46F7-A0F2-5FFC6A1EC985Q54446002-FBC78D83-FF5A-460B-AAFB-9662BADC6AC5
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Expression of NDRG2 in clear cell renal cell carcinoma.
@en
Expression of NDRG2 in clear cell renal cell carcinoma.
@nl
type
label
Expression of NDRG2 in clear cell renal cell carcinoma.
@en
Expression of NDRG2 in clear cell renal cell carcinoma.
@nl
prefLabel
Expression of NDRG2 in clear cell renal cell carcinoma.
@en
Expression of NDRG2 in clear cell renal cell carcinoma.
@nl
P2093
P356
P1476
Expression of NDRG2 in clear cell renal cell carcinoma.
@en
P2093
Haifeng Jin
Huadong Zhao
Jianjun Ma
Jianlin Yuan
Tingyi Bao
P304
P356
10.1248/BPB.31.1316
P577
2008-07-01T00:00:00Z